Physician profile
Dan M Dorough
NPI 1417011289
$991.59
in general payments reported to CMS, 2019-2025
17 companies · $17.19 in 2025
The $17.19 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $314 · 2022: $61.57 · 2023: $96.28 · 2024: $148 · 2025: $17.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $261.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $149.86 | 2019-2020 | |
| Coopersurgical, INC. | $134.57 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $133.95 | 2019-2024 | Aptima, Thinprep 2000 Processor |
| Allergan, INC. | $83.29 | 2019-2020 | |
| Organon LLC | $71.16 | 2023-2024 | Nexplanon |
| Lupin INC. | $69.36 | 2019-2020 | |
| Pfizer INC. | $65.19 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $54.22 | 2019-2020 | |
| Covidien Lp | $52.14 | 2019 | |
| Therapeuticsmd, INC. | $48.37 | 2020 | |
| Myovant Sciences INC. | $26.69 | 2022 | |
| Exeltis, USA INC. | $22.95 | 2024 | Slynd |
| Agile Therapeutics, INC. | $18.03 | 2024 | Twirla |
| Octapharma USA, INC. | $17.19 | 2025 | Fibryga |
| Avanos Medical | $15.66 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $15.34 | 2019 | |
| Aspira Women'S Health INC | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Dorough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.